EP4784593A2 - Oligonukleotidzusammensetzungen und verfahren dafür - Google Patents
Oligonukleotidzusammensetzungen und verfahren dafürInfo
- Publication number
- EP4784593A2 EP4784593A2 EP24873786.8A EP24873786A EP4784593A2 EP 4784593 A2 EP4784593 A2 EP 4784593A2 EP 24873786 A EP24873786 A EP 24873786A EP 4784593 A2 EP4784593 A2 EP 4784593A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- fl2r
- ssp
- oligonucleotide
- nucleoside
- oligonucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363586381P | 2023-09-28 | 2023-09-28 | |
| PCT/US2024/049133 WO2025072881A2 (en) | 2023-09-28 | 2024-09-27 | Oligonucleotide compositions and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4784593A2 true EP4784593A2 (de) | 2026-08-05 |
Family
ID=95201352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24873786.8A Pending EP4784593A2 (de) | 2023-09-28 | 2024-09-27 | Oligonukleotidzusammensetzungen und verfahren dafür |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4784593A2 (de) |
| CN (1) | CN122341621A (de) |
| AU (1) | AU2024351975A1 (de) |
| WO (2) | WO2025072881A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014010250A1 (en) | 2012-07-13 | 2014-01-16 | Chiralgen, Ltd. | Asymmetric auxiliary group |
| MA46427A (fr) | 2015-10-09 | 2018-08-15 | Wave Life Sciences Ltd | Compositions d'oligonucléotides et procédés associés |
| MX2021012981A (es) | 2019-04-25 | 2022-01-18 | Wave Life Sciences Ltd | Composiciones de oligonucleotido y metodos de uso de las mismas. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019392928A1 (en) * | 2018-12-06 | 2021-06-17 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods thereof |
| EP3978608A1 (de) * | 2020-10-05 | 2022-04-06 | SQY Therapeutics | Oligomere verbindung zur dystrophinrettung in dmd-patienten während des skipping exon-51 |
| JP2023548584A (ja) * | 2020-11-08 | 2023-11-17 | ウェイブ ライフ サイエンシズ リミテッド | オリゴヌクレオチド組成物及びその方法 |
-
2024
- 2024-09-27 EP EP24873786.8A patent/EP4784593A2/de active Pending
- 2024-09-27 WO PCT/US2024/049133 patent/WO2025072881A2/en not_active Ceased
- 2024-09-27 CN CN202480074333.0A patent/CN122341621A/zh active Pending
- 2024-09-27 AU AU2024351975A patent/AU2024351975A1/en active Pending
-
2025
- 2025-09-26 WO PCT/US2025/048308 patent/WO2026073042A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025072881A9 (en) | 2025-05-15 |
| WO2026073042A8 (en) | 2026-05-28 |
| AU2024351975A1 (en) | 2026-04-16 |
| CN122341621A (zh) | 2026-07-03 |
| WO2025072881A2 (en) | 2025-04-03 |
| WO2026073042A1 (en) | 2026-04-02 |
| WO2025072881A3 (en) | 2025-06-12 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20260424 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |